Related Experiment Video

Updated: Dec 31, 2025

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling
09:08

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling

Published on: October 14, 2021

6.1K

Antecedent chronic lymphocytic leukemia may be associated with more aggressive mycosis fungoides

Amrita Goyal1, Daniel O'Leary2, Kimberly Bohjanen3

  • 1Medicine/Dermatology program, University of Minnesota, Minneapolis, USA.

Cutis
|December 31, 2019
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma
10:52

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Published on: March 30, 2018

11.6K
Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
06:08

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

Published on: February 10, 2023

1.7K

Related Experiment Videos

Last Updated: Dec 31, 2025

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling
09:08

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling

Published on: October 14, 2021

6.1K
Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma
10:52

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Published on: March 30, 2018

11.6K
Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
06:08

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

Published on: February 10, 2023

1.7K

Related Concept Videos

Skin Diseases and Disorders01:23

Skin Diseases and Disorders

5.1K
Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
5.1K

Articles linked to this work by shared authors, journal, and citation graph.

Aggressive Cytotoxic Lymphomas of the Auricle: An Under-recognized Presentation.

The American Journal of dermatopathology·2026

Talquetamab-Daratumumab in Relapsed or Refractory Myeloma.

The New England journal of medicine·2026

Minimally invasive surgical resection reduces one-year mortality, especially in high-risk colon cancer patients: an emulated trial.

EClinicalMedicine·2026

Estimated effect of correcting inequalities in minimally invasive surgical resection in patients with colon cancer in England: a population-based study.

The Lancet. Oncology·2026

An evaluation of denileukin diftitox for the treatment of relapsed or refractory cutaneous T-cell lymphoma.

Expert opinion on biological therapy·2025

CAR-T for multiple myeloma: practice pearls.

Bone marrow transplantation·2025

Association Between Hidradenitis Suppurativa and Polycystic Ovary Syndrome.

Cutis·2026

Medical Decision-Making in Evaluation and Management Coding: Practical Applications and Key Clarifications.

Cutis·2026

Using Intralesional Adalimumab for Chronic Refractory Cutaneous Granulomatous Inflammation.

Cutis·2026

Getting a Grip on Occupational Hand Dermatitis: Key Considerations for Evaluation and Management.

Cutis·2026

Horse Flies: Identification, Bite Reactions, and Clinical Management.

Cutis·2026

Pembrolizumab-Induced Bullous Pemphigoid: Navigating Diagnostic Challenges and Treatment Resistance.

Cutis·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us